Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Multiple sclerosis risk loci and disease severity in 7,125 individuals from 10 studies.
Pharmacodynamics, pharmacokinetics, and safety of multiple doses of FTY720 in stable renal transplant patients: a multicenter, randomized, placebo-controlled, phase I study.
Recommendations for the management of multiple sclerosis relapses.
Transplantation of umbilical cord and bone marrow-derived mesenchymal stem cells in a patient with relapsing-remitting multiple sclerosis.
Optic nerve magnetisation transfer ratio after acute optic neuritis predicts axonal and visual outcomes.
Early Treatment with Anti-VLA-4 mAb Can Prevent the Infiltration and/or Development of Pathogenic CD11b+CD4+ T Cells in the CNS during Progressive EAE.
Solitary sclerosis: progressive myelopathy from solitary demyelinating lesion. A new entity?
Short and long term variation in ultraviolet radiation and multiple sclerosis.
Agreement between physician's recommendation and fitness-to-drive decision in multiple sclerosis.
New technologies for biomarker discovery in multiple sclerosis.
A Study of the Safety and Efficacy of ONO-4641 in Patients With Relapsing-Remitting Multiple Sclerosis (DreaMS)
Information on natalizumab (marketed as Tysabri)
Therapeutic protein-drug interaction assessment for daclizumab high-yield process in patients with multiple sclerosis using a cocktail approach.
Fingolimod for multiple sclerosis: a review for the specialist nurse.
Distinct serum cytokine profiles in neuromyelitis optica and multiple sclerosis.
Neurorestorative effect of FTY720 in a rat model of Alzheimer's disease: Comparison with Memantine.
Alemtuzumab 3-year data show durable effect on MS disability
Nerve Conduction Velocity Is Regulated by the Inositol Polyphosphate-4-Phosphatase II Gene.
Polyunsaturated fatty acids in multiple sclerosis therapy.
Structure and Activity of the Acid Sensing Ion Channels.
Riluzole-induced block of voltage-gated Na+ current and activation of BKCa channels in cultured differentiated human skeletal muscle cells.
Therapeutic efficacy of IL-17 neutralization in murine experimental autoimmune encephalomyelitis.
Lack of response to pulse cyclophosphamide in neuromyelitis optica: evaluation of 7 patients.
MSQoL-54 predicts change in fatigue after inpatient rehabilitation for people with multiple sclerosis.
Inhibition of the development of chronic experimental autoimmune encephalomyelitis by laquinimod (ABR-215062) in IFN-beta k.o. and wild type mice.

Pages